Sanjay Basumatary | Chemistry and Materials Science | Best Researcher Award

Posted on by sciencefather

Prof. Sanjay Basumatary | Chemistry and Materials Science | Best Researcher Award

Professor at Bodoland University, India.

Dr. Sanjay Basumatary is a distinguished academician and researcher in Chemistry, currently serving as Professor and Head of the Department of Chemistry at Bodoland University, India. He holds a Ph.D. in Chemistry from Gauhati University, with expertise in renewable energy, biodiesel production, catalysis, phytochemistry, and adsorption studies. Throughout his career, Dr. Basumatary has demonstrated strong research acumen, proficient in experimental design, analytical techniques, data analysis, and literature synthesis. He has received prestigious awards including the CSIR-UGC NET and UGC Rajiv Gandhi National JRF, recognizing his contributions to the field. Dr. Basumatary is committed to advancing sustainable practices and has a robust publication record, presenting his research globally to foster collaborations and innovation in Chemistry.

Professional Profiles:

Education šŸŽ“

Dr. Sanjay Basumatary pursued his academic journey in Chemistry with a Ph.D. from Gauhati University, Guwahati, completing his thesis on “Transesterification of Non-edible Vegetable Oils Using a Novel Catalyst Derived from Banana Plant and Technical Assessment of the Products as Biodiesel” in 2012. Prior to his doctoral studies, he earned his M.Sc. in Organic Chemistry from the same institution in 2007. His undergraduate education began at Kokrajhar Govt. College, where he obtained a B.Sc. in Chemistry in 2005. These educational achievements have equipped Dr. Basumatary with a strong foundation in Chemistry, facilitating his subsequent career in academia and research at Bodoland University, where he currently serves as Professor and Head of the Department of Chemistry.

Professional Experience

Dr. Sanjay Basumatary has built a distinguished career in academia, specializing in Chemistry. Currently serving as Professor and Head of the Department of Chemistry at Bodoland University, Kokrajhar, he has been instrumental in shaping the academic landscape. His journey began as an Assistant Professor at Bineswar Brahma Engineering College, Kokrajhar, where he taught from August 2010 to August 2014. Subsequently, he joined Bodoland University as an Assistant Professor in August 2014 and steadily progressed to the position of Assistant Professor (Senior Scale) before assuming the role of Professor in November 2021. Throughout his career, Dr. Basumatary has also held various administrative roles within the Department of Chemistry, including several stints as Acting Head and currently as Head since December 2021. His tenure has been marked by significant contributions to teaching, research guidance, and administrative leadership, consolidating his reputation as a respected figure in the field of Chemistry education and research.

Research Interest

Dr. Sanjay Basumatary’s research interests encompass a broad spectrum within Chemistry, focusing particularly on areas crucial to sustainable development and innovation. His primary research interests include Renewable Energy, with a specific emphasis on Biodiesel production and catalysis. Additionally, he delves into Phytochemistry, exploring the chemical composition and properties of natural products derived from plants. His research also extends to Adsorption studies, investigating the application of adsorbents in environmental and industrial contexts. Through his multifaceted research endeavors, Dr. Basumatary contributes significantly to advancing knowledge and solutions in these critical areas of Chemistry.

Award and Honors

Dr. Sanjay Basumatary has received notable awards and honors in recognition of his academic and research contributions. He was awarded the CSIR-UGC NET in 2009, highlighting his expertise in Chemistry and qualifying him for national-level research fellowships. Additionally, he earned the prestigious UGC Rajiv Gandhi National Junior Research Fellowship (JRF) from 2008 to 2010, further underscoring his dedication to advancing research in his field. These accolades reflect Dr. Basumatary’s commitment to excellence in academia and his significant contributions to the field of Chemistry, particularly in sustainable energy and natural product chemistry.

Research Skills

Dr. Sanjay Basumatary possesses a diverse range of research skills crucial to his contributions in Chemistry. His expertise encompasses proficient experimental design and execution, particularly in areas such as renewable energy, biodiesel production, catalysis, phytochemistry, and adsorption studies. He is adept at employing various analytical techniques, including spectroscopy (UV-Vis, IR), chromatography (GC-MS, HPLC), and microscopy (SEM, TEM) for detailed chemical analysis and characterization. Dr. Basumatary excels in data analysis, employing statistical methods to interpret experimental results effectively and derive meaningful conclusions. Furthermore, he demonstrates strong capabilities in conducting thorough literature reviews to establish the theoretical foundations of his research. He has a proven track record in publishing research findings in esteemed journals and presenting his work at national and international conferences. Additionally, his skills extend to grant writing, project management, and fostering collaborative research efforts, underscoring his commitment to advancing knowledge and innovation in Chemistry.

Publications

  1. High quality biodiesel from yellow oleander (Thevetia peruviana) seed oil
    • Authors: DC Deka, S Basumatary
    • Year: 2011
    • Citations: 226
  2. Biodiesel production from mixed oils: A sustainable approach towards industrial biofuel production
    • Authors: S Brahma, B Nath, B Basumatary, B Das, P Saikia, K Patir, S Basumatary
    • Year: 2022
    • Citations: 190
  3. Waste to value addition: Utilization of waste Brassica nigra plant derived novel green heterogeneous base catalyst for effective synthesis of biodiesel
    • Authors: B Nath, B Das, P Kalita, S Basumatary
    • Year: 2019
    • Citations: 168
  4. Highly efficient renewable heterogeneous base catalyst derived from waste Sesamum indicum plant for synthesis of biodiesel
    • Authors: B Nath, P Kalita, B Das, S Basumatary
    • Year: 2020
    • Citations: 109
  5. Utilization of renewable and sustainable basic heterogeneous catalyst from Heteropanax fragrans (Kesseru) for effective synthesis of biodiesel from Jatropha curcas oil
    • Authors: S Basumatary, B Nath, B Das, P Kalita, B Basumatary
    • Year: 2021
    • Citations: 101
  6. Application of agro-waste derived materials as heterogeneous base catalysts for biodiesel synthesis
    • Authors: S Basumatary, B Nath, P Kalita
    • Year: 2018
    • Citations: 81
  7. Waste Musa paradisiaca plant: an efficient heterogeneous base catalyst for fast production of biodiesel
    • Authors: B Basumatary, S Basumatary, B Das, B Nath, P Kalita
    • Year: 2021
    • Citations: 74
  8. Transesterification with heterogeneous catalyst in production of biodiesel: A Review
    • Authors: S Basumatary
    • Year: 2013
    • Citations: 69
  9. Production of renewable biodiesel using metal organic frameworks based materials as efficient heterogeneous catalysts
    • Authors: SF Basumatary, K Patir, B Das, P Saikia, S Brahma, B Basumatary, B Nath
    • Year: 2022
    • Citations: 63
  10. Biodiesel as renewable biofuel produced via enzyme-based catalyzed transesterification
    • Authors: P Kalita, B Basumatary, P Saikia, B Das, S Basumatary
    • Year: 2022
    • Citations: 61
  11. Non-conventional seed oils as potential feedstocks for future biodiesel industries: a brief review
    • Authors: S Basumatary
    • Year: 2013
    • Citations: 60

 

 

 

DEROSA LISA | Immunology and Microbiology | Best Researcher Award

Posted on by sciencefather

Assist Prof Dr. DEROSA LISA | Immunology and Microbiology | Best Researcher Award

MD, PhD at Gustave Roussy, France.

Associate Professor Dr. Lisa Derosa is a leading medical oncologist and researcher at Gustave Roussy Cancer Center (GRCC) in France, specializing in tumor immunology and cancer immunotherapy. With an MD from Pisa University and a PhD in Immunology from Paris-Sud University, she has significantly contributed to understanding the immunosuppressive role of antibiotics and the impact of gut microbiota on antitumor immunity. Since 2016, Dr. Derosa has pioneered research in these areas, earning numerous prestigious awards including the Conquer Cancer Foundation ASCO Merit Award and recognitions from ESMO and European Urology. She directs the ClinicoBiome Program at GRCC and co-directs the RHU Clinical Program Grant ā€œImmunolifeā€ and the EU Program Grant ā€œOncobiome.ā€ Her research skills include clinical trial design, metagenomic analysis, immunological assays, and pharmacodynamic studies, making her a leader in microbiota-centered cancer therapies. Dr. Derosaā€™s collaborative approach and interdisciplinary projects have resulted in over 100 publications and significant advancements in cancer immunotherapy.

Professional Profiles:

Education

Associate Professor Dr. Lisa Derosa’s educational journey is marked by a series of prestigious degrees and certifications. In 2023, she became an Associate Professor of Immunology at Paris-Saclay University in France. Prior to that, in 2019, she earned her PhD in Immunology from Paris-Sud University and registered as a physician in France the same year. She also obtained a University Diploma in Animal Experimentation Level 1 from Sorbonne University, Paris, in 2018. Her earlier academic achievements include a DiplĆ“me Universitaire EuropĆ©en de Recherche Translationnelle Et Clinique en CancĆ©rologie (DUERTECC) from Paris-Sud University and a DiplĆ“me dā€™UniversitĆ© Carcinologie ClĆ­niques (DUC) from UniversitĆ© Paris XI, both in 2016. Dr. Derosa completed her M2 in Pharmacology, Clinical Trial in Oncology at Pisa University in Italy in 2015 and became Board Certified in Medical Oncology from the same university in 2014. She first qualified as a physician in Italy in 2009, following her MD from the School of Medicine at Pisa University in 2008.

Professional Experience

Associate Professor Dr. Lisa Derosa has a distinguished career in medical oncology and cancer immunology. Since 2022, she has been serving as the Co-Coordinator of the RHU IMMUNOLIFE (PIA2) multi-team program project in France and as a member of the Scientific Advisory Board for everImmune. In the same year, she was appointed as an Associate Professor of Immunology at Paris-Saclay University and a Senior Research Associate in the Cancer Immunology Department at Gustave Roussy Cancer Center (GRCC). Dr. Derosa has also been the Clinical Director of the ClinicoBiome Program at GRCC since 2020 and has held the position of Medical Oncology Specialist at GRCC since 2020. From 2017 to 2021, she co-coordinated the PIA2 RHU TORINO LUMIERE project. She has also been a Co-Coordinator of the H2020 ONCOBIOME project since 2019. Prior to these roles, Dr. Derosa served as a clinical attending in the Genitourinary and Lung Department at GRCC from 2019 to 2020 and completed a clinical fellowship in the Genitourinary Medical Oncology Department at GRCC from 2016 to 2019. Before joining GRCC, she was a clinical attending in the Oncology Department at Hospital S. Chiara-Pisa from 2014 to 2016. Additionally, she gained valuable experience as a visiting student at GRCC in 2013 and at the Oncology Department at Ospedali Riuniti di Livorno from 2006 to 2008.

Award and Honors

Associate Professor Dr. Lisa Derosa has received numerous prestigious awards and honors throughout her career, reflecting her significant contributions to oncology and immunology. In 2023, she was honored with the Conquer Cancer Foundation ASCO Merit Award. The previous year, she received an accolade from the European Society for Medical Oncology (ESMO) at their Asia Annual Meeting. In 2021, she was awarded the Best Scientific Paper published on Fundamental Research by European Urology and also received the ASCO Merit Award in Lung Cancer, supported by Frances A. Shepherd. Her exceptional work earned her the EATI Award in 2020. The year 2018 was particularly notable, as she received the Best Paper Award from ESMO YOC, the ESMO Annual Meeting Award, the Early Detection of Cancer Conference Award from ARC, and the Conquer Cancer Foundation ASCO Merit Award. In 2017, she was recognized with multiple Conquer Cancer Foundation ASCO Merit Awards, including the Genitourinary Cancer Merit Award. In 2016, she was the recipient of the 5th Pieter de Mulder Memorial Prize and the ESMO Translational Research Fellowship Award. Her early career was distinguished by the AIOM Award for young researchers in Oncology in 2015, the ESMO Annual Meeting Award in 2014, and the ITT Stage in Oncology Award from the Istituto Toscano Tumori in 2013.

Research Interest

Associate Professor Dr. Lisa Derosaā€™s research interests lie at the intersection of tumor immunology and cancer immunotherapy, with a particular focus on the immunosuppressive role of antibiotics in cancer treatment and the impact of gut microbiota on antitumor immunity. Since 2016, she has been pioneering research in these areas, exploring how the composition of gut microbiota can regulate the effectiveness of immune checkpoint inhibitors. Her innovative work has led to significant insights into the microbiotaā€™s role in cancer treatment, making her a leading figure in the development of microbiota-centered interventions. Dr. Derosa currently directs the Microbiota-Centered Intervention Program (ClinicoBiome) at Gustave Roussy Cancer Center and co-directs the RHU Clinical Program Grant ā€œImmunolifeā€ as well as the EU Program Grant ā€œOncobiome.ā€ Her research continues to bridge clinical oncology with translational research, aiming to improve patient outcomes through a deeper understanding of the immune systemā€™s interactions with cancer therapies.

Research Skills

Associate Professor Dr. Lisa Derosa possesses a comprehensive skill set in the field of cancer immunology and immunotherapy, characterized by her expertise in clinical and translational research. She has extensive experience in designing and conducting clinical trials, particularly those investigating the interactions between gut microbiota and immune checkpoint inhibitors. Dr. Derosa is skilled in metagenomic analysis, allowing her to identify microbiome-based biomarkers that predict patient response to immunotherapy. Her proficiency in immunological assays and molecular biology techniques has been instrumental in her research on the immunosuppressive effects of antibiotics and the regulatory role of gut microbiota in antitumor immunity. Additionally, she has a strong background in pharmacodynamic and pharmacokinetic studies, which she has applied in various phase II clinical trials. Dr. Derosaā€™s ability to integrate clinical data with cutting-edge laboratory research has made her a leader in the development of microbiota-centered cancer therapies. Her collaborative projects often involve multidisciplinary teams, highlighting her skills in project management and scientific communication.